- Q4 2023 Sedana Medical AB (publ) Earnings Call TranscriptFeb 15, 2024kr18.93 (-5.11%)Earnings
- Q3 2023 Sedana Medical AB (publ) Earnings Call TranscriptOct 26, 2023kr17.23 (-4.44%)Earnings
- Q2 2023 Sedana Medical AB (publ) Earnings Call TranscriptJul 21, 2023kr24.64 (+10.69%)Earnings
- Q1 2023 Sedana Medical AB (publ) Earnings Call TranscriptApr 27, 2023kr24.92 (+7.69%)Earnings
- Q4 2022 Sedana Medical AB (publ) Earnings Call TranscriptFeb 16, 2023kr23.68 (+11.38%)Earnings
- Sedana Medical AB (publ) at Redeye Medtech Seminar (Virtual) TranscriptOct 26, 2022
- Q3 2022 Sedana Medical AB (publ) Earnings Call TranscriptOct 25, 2022kr20 (-21.94%)Earnings
- Q2 2022 Sedana Medical AB (publ) Earnings Call TranscriptJul 21, 2022kr24.02 (+9.68%)Earnings
- Q1 2022 Sedana Medical AB (publ) Earnings Call TranscriptApr 28, 2022kr33.9 (-30.82%)Earnings
- Q4 2021 Sedana Medical AB (publ) Earnings Call TranscriptFeb 17, 2022kr71.35 (+2.51%)Earnings
- Q3 2021 Sedana Medical AB (publ) Earnings Call TranscriptNov 04, 2021kr88.05 (+7.38%)Earnings
- Q2 2021 Sedana Medical AB (publ) Earnings Call TranscriptAug 19, 2021kr82.45 (-3.90%)Earnings
- Q1 2021 Sedana Medical AB (publ) Earnings Call TranscriptMay 06, 2021kr82.25 (-3.80%)Earnings
- Full Year 2020 Sedana Medical AB (publ) Earnings Call TranscriptFeb 25, 2021kr91 (+2.97%)Earnings
Q4 2022 Sedana Medical AB (publ) Earnings Call Transcript
Welcome to the Sedana Q4 Report 2022. (Operator Instructions) Now I will hand the conference over to CEO and President, Johannes Doll. Please go ahead.
()-&
Good afternoon. Welcome, everybody, to Sedana Medical's Q4 and Full Year Report 2022. With me, I have Peter Sackey, our Chief Medical Officer; and Johan Spetz, our CFO. And what we will do, I will start by taking you through our performance in Q4, and we will have a look at the progress we have made with regards to our 2 main strategic priorities, rolling out inhaled sedation in Europe and preparing for the U.S. market, including our clinical program that Peter will speak about, and Johan will show you our numbers in a bit more depth before I will wrap it up, and we, of course, discuss your questions.
As always, there are some predictions we are making about the future. So when you have a minute, please give our disclaimer on Page 2 a quick read.
Let's start on Page 3, please, with the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)